Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 19

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Mechanisms of Aberrant PKA Activation by Cα Subunit Mutations

Calebiro, D., Bathon, K., Weigand, I. · 2017 · Hormone and Metabolic Research

Abstract

Somatic mutations in PRKACA, coding for the catalytic α subunit of protein kinase A (PKA), have been recently identified as the most frequent genetic alteration in cortisol-secreting adrenocortical adenomas, which are responsible for adrenal Cushing’s syndrome. The mutations identified so far lie at the interface between the catalytic (C) and regulatory (R) subunit of PKA. Detailed functional studies of the most frequent of these mutations (L206R) as well as of another one in the same region of the C subunit (199_200insW) have revealed that these mutations cause constitutive activation of PKA and lack of regulation by cAMP. This is due to interference with the binding of the R subunit, which keeps the C subunit inactive in the absence of cyclic AMP. Here, we review these recent findings, with a particular focus on the mechanisms of action of PRKACA mutations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1055/s-0042-112817

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 64

  1. K L Pierce, 2002, Seven-transmembrane receptors, Nat Rev Mol Cell Biol, 3, 639, 10.1038/nrm908 · DOI · Paper page
  2. S S Taylor, 2012, Assembly of allosteric macromolecular switches: lessons from PKA, Nat Rev Mol Cell Biol, 13, 646, 10.1038/nrm3432 · DOI · Paper page
  3. I Bossis, 2004, Minireview: PRKAR1A: Normal and Abnormal Functions, Endocrinology, 145, 5452, 10.1210/en.2004-0900 · DOI · Paper page
  4. A G Lania, 2006, Mechanisms of Disease: mutations of G proteins and G-protein-coupled receptors in endocrine diseases, Nat Clin Pract End Met, 2, 681, 10.1038/ncpendmet0324 · DOI
  5. J Lyons, 1990, Two G protein oncogenes in human endocrine tumors, Science, 249, 655, 10.1126/science.2116665 · DOI · Paper page
  6. J Parma, 1993, Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas, Nature, 365, 649, 10.1038/365649a0 · DOI · Paper page
  7. L Vallar, 1987, Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas, Nature, 330, 566, 10.1038/330566a0 · DOI · Paper page
  8. C A Landis, 1989, GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours, Nature, 340, 692, 10.1038/340692a0 · DOI · Paper page
  9. L S Weinstein, 1991, Activating mutations of the stimulatory G protein in the McCune-Albright syndrome, N Engl J Med, 325, 1688, 10.1056/NEJM199112123252403 · DOI · Paper page
  10. J A Carney, 2011, Primary bimorphic adrenocortical disease: cause of hypercortisolism in McCune-Albright syndrome, Am J Surg Pathol, 35, 1311, 10.1097/PAS.0b013e31821ec4ce · DOI
  11. S Espiard, 2014, Protein kinase A alterations in adrenocortical tumors, Horm Metab Res, 46, 869, 10.1055/s-0034-1385908 · DOI
  12. E L Greene, 2008, In vitro functional studies of naturally occurring pathogenic PRKAR1A mutations that are not subject to nonsense mRNA decay, Hum Mutat, 29, 633, 10.1002/humu.20688 · DOI
  13. M Guillaud Bataille, 2014, Systematic screening for PRKAR1A gene rearrangement in Carney complex: identification and functional characterization of a new in-frame deletion, Eur J Endocrinol, 170, 151, 10.1530/EJE-13-0740 · DOI
  14. L Groussin, 2002, Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease, J Clin Endocrinol Metab, 87, 4324, 10.1210/jc.2002-020592 · DOI · Paper page
  15. E Meoli, 2008, Protein kinase A effects of an expressed PRKAR1A mutation associated with aggressive tumors, Cancer Res, 68, 3133, 10.1158/0008-5472.CAN-08-0064 · DOI
  16. A Linglart, 2011, Recurrent PRKAR1A mutation in acrodysostosis with hormone resistance, N Engl J Med, 364, 2218, 10.1056/NEJMoa1012717 · DOI · Paper page
  17. Y Rhayem, 2015, Functional Characterization of PRKAR1A Mutations Reveals a Unique Molecular Mechanism Causing Acrodysostosis but Multiple Mechanisms Causing Carney Complex, J Biol Chem, 290, 27816, 10.1074/jbc.M115.656553 · DOI
  18. E Szarek, 2014, Phosphodiesterases and Adrenal Cushing in Mice and Humans, Horm Metab Res, 46, 863, 10.1055/s-0034-1389916 · DOI
  19. P Salpea, 2014, Carney complex and McCune Albright syndrome: An overview of clinical manifestations and human molecular genetics, Mol Cell Endocrinol, 386, 85, 10.1016/j.mce.2013.08.022 · DOI
  20. F Beuschlein, 2014, Constitutive activation of PKA catalytic subunit in adrenal Cushing’s syndrome, N Engl J Med, 370, 1019, 10.1056/NEJMoa1310359 · DOI · Paper page
  21. G Goh, 2014, Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors, Nat Genet, 46, 613, 10.1038/ng.2956 · DOI · Paper page
  22. Y Sato, 2014, Recurrent somatic mutations underlie corticotropin-independent Cushing’s syndrome, Science, 344, 917, 10.1126/science.1252328 · DOI · Paper page
  23. D A Johnson, 2001, Dynamics of cAMP-Dependent Protein Kinase, Chem Rev, 101, 2243, 10.1021/cr000226k · DOI · Paper page
  24. D Knighton, 1991, Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase, Science, 253, 407, 10.1126/science.1862342 · DOI · Paper page
  25. M Diskar, 2010, Regulation of cAMP-dependent Protein Kinases: The human protein kinase X (PrKX) reveals the role of the catalytic subunit aH-aI loop, J Biol Chem, 285, 35910, 10.1074/jbc.M110.155150 · DOI
  26. S S Taylor, 2013, PKA: lessons learned after twenty years, Biochim Biophys Acta, 1834, 1271, 10.1016/j.bbapap.2013.03.007 · DOI · Paper page
  27. D W Carr, 1991, Interaction of the regulatory subunit (RII) of cAMP-dependent protein kinase with RII-anchoring proteins occurs through an amphipathic helix binding motif, J Biol Chem, 266, 14188, 10.1016/S0021-9258(18)98665-5 · DOI · Paper page
  28. F S Kinderman, 2006, A Novel and Dynamic Mechanism for AKAP Binding to RII Isoforms of cAMP-dependent Protein Kinase, Mol Cell, 24, 397, 10.1016/j.molcel.2006.09.015 · DOI · Paper page
  29. W Weber, 1979, Stoichiometry of cAMP binding and limited proteolysis of protein kinase regulatory subunits R I and R II, Biochem Biophys Res Commun, 90, 1073, 10.1016/0006-291X(79)91935-1 · doi:10.1016/0006-291x(79)91935-1
  30. S S Taylor, 1990, cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes, Annu Rev Biochem, 59, 971, 10.1146/annurev.bi.59.070190.004543 · DOI · Paper page
  31. P Zhang, 2012, Structure and Allostery of the PKA RIIb Tetrameric Holoenzyme, Science, 335, 712, 10.1126/science.1213979 · DOI · Paper page
  32. C Kim, 2007, PKA-I Holoenzyme Structure Reveals a Mechanism for cAMP-Dependent Activation, Cell, 130, 1032, 10.1016/j.cell.2007.07.018 · DOI · Paper page
  33. T J Sjoberg, 2010, Dissecting the cAMP-inducible allosteric switch in protein kinase A RIa, Protein Sci, 19, 1213, 10.1002/pro.400 · DOI
  34. C M Smith, 1999, The catalytic subunit of cAMP-dependent protein kinase: prototype for an extended network of communication, Prog Biophys Mol Biol, 71, 313, 10.1016/S0079-6107(98)00059-5 · DOI
  35. A C Bastidas, 2013, Phosphoryl transfer by protein kinase A is captured in a crystal lattice, J Am Chem Soc, 135, 4788, 10.1021/ja312237q · DOI · Paper page
  36. A C Bastidas, 2015, Molecular Features of Product Release for the PKA Catalytic Cycle, Biochemistry, 54, 2, 10.1021/bi500684c · DOI
  37. K Srivastava Atul, 2014, Synchronous Opening and Closing Motions Are Essential for cAMP-Dependent Protein Kinase A Signaling, Structure, 22, 1735, 10.1016/j.str.2014.09.010 · DOI · Paper page
  38. S S Taylor, 2004, PKA: a portrait of protein kinase dynamics, Biochim Biophys Acta, 1697, 259, 10.1016/j.bbapap.2003.11.029 · DOI · Paper page
  39. J Wu, 2007, PKA type IIalpha holoenzyme reveals a combinatorial strategy for isoform diversity, Science, 318, 274, 10.1126/science.1146447 · DOI · Paper page
  40. J Arnold, 1866, Ein Beitrag zu der feineren Structur und dem Chemismus der Nebennieren, Arch Pathol Anatom Physiol Klin Med, 35, 64, 10.1007/BF01979887 · DOI
  41. T J Rosol, 2001, Adrenal Gland: Structure, Function, and Mechanisms of Toxicity, Toxicol Pathol, 29, 41, 10.1080/019262301301418847 · DOI · Paper page
  42. J Drouin, 2007, Of old and new diseases: genetics of pituitary ACTH excess (Cushing) and deficiency, Clin Genet, 72, 175, 10.1111/j.1399-0004.2007.00877.x · DOI
  43. F Beuschlein, 2001, ACTH-receptor expression, regulation and role in adrenocortical tumor formation, Eur J Endocrinol, 144, 199, 10.1530/eje.0.1440199 · DOI
  44. I Kojima, 1985, Role of calcium and cAMP in the action of adrenocorticotropin on aldosterone secretion, J Biol Chem, 260, 4248, 10.1016/S0021-9258(18)89257-2 · DOI · Paper page
  45. A Weber, 1993, Functional Characterization of the Cloned Human ACTH Receptor: Impaired Responsiveness of a Mutant Receptor in Familial Glucocorticoid Deficiency, Biochem Biophys Res Commun, 197, 172, 10.1006/bbrc.1993.2456 · DOI
  46. C Kim, 2005, Crystal structure of a complex between the catalytic and regulatory (RIalpha) subunits of PKA, Science, 307, 690, 10.1126/science.1104607 · DOI · Paper page
  47. D M Stocco, 2005, Multiple signaling pathways regulating steroidogenesis and steroidogenic acute regulatory protein expression: more complicated than we thought, Mol Endocrinol, 19, 2647, 10.1210/me.2004-0532 · DOI · Paper page
  48. M B Sewer, 2007, Transcriptional regulation of adrenocortical steroidogenic gene expression, Drug Metab Rev, 39, 371, 10.1080/03602530701498828 · DOI
  49. J C Chrivia, 1993, Phosphorylated CREB binds specifically to the nuclear protein CBP, Nature, 365, 855, 10.1038/365855a0 · DOI · Paper page
  50. D Rosenberg, 2002, Role of the PKA-regulated transcription factor CREB in development and tumorigenesis of endocrine tissues, Ann N Y Acad Sci, 968, 65, 10.1111/j.1749-6632.2002.tb04327.x · DOI · Paper page
  51. E H Cameron, 1968, The role of progesterone in the biosynthesis of cortisol in human adrenal tissue, J Endocrinol, 41, 319, 10.1677/joe.0.0410319 · DOI
  52. A J Clark, 2009, The genetics of familial glucocorticoid deficiency, Best Pract Res Clin Endocrinol Metab, 23, 159, 10.1016/j.beem.2008.09.006 · DOI
  53. D Chida, 2007, Melanocortin 2 receptor is required for adrenal gland development, steroidogenesis, and neonatal gluconeogenesis, Proc Natl Acad Sci USA, 104, 18205, 10.1073/pnas.0706953104 · DOI · Paper page
  54. A P Coll, 2004, The effects of proopiomelanocortin deficiency on murine adrenal development and responsiveness to adrenocorticotropin, Endocrinology, 145, 4721, 10.1210/en.2004-0491 · DOI
  55. P J Hornsby, 1977, Hormonal-Control of Adrenocortical Cell-Proliferation - Desensitization to Acth and Interaction between Acth and Fibroblast Growth-Factor in Bovine Adrenocortical Cell-Cultures, J Clin Invest, 60, 342
  56. G E Mattos, 2011, Comparative effect of FGF2, synthetic peptides 1-28N-POMC and ACTH on proliferation in rat adrenal cell primary cultures, Cell Tissue Res, 345, 343, 10.1007/s00441-011-1220-8 · DOI
  57. J Karpac, 2005, Development, maintenance, and function of the adrenal gland in early postnatal proopiomelanocortin-null mutant mice, Endocrinology, 146, 2555, 10.1210/en.2004-1290 · DOI
  58. M Fassnacht, 2003, N-Terminal Proopiomelanocortin Acts as a Mitogen in Adrenocortical Tumor Cells and Decreases Adrenal Steroidogenesis, J Clin Endocrinol Metab, 88, 2171, 10.1210/jc.2002-021318 · DOI
  59. D Calebiro, 2014, PKA catalytic subunit mutations in adrenocortical Cushing’s adenoma impair association with the regulatory subunit, Nat Commun, 5, 5680, 10.1038/ncomms6680 · DOI · Paper page
  60. D Calebiro, 2015, cAMP signaling in cortisol producing adrenal adenoma, Eur J Endocrinol, 173, M99, 10.1530/EJE-15-0353 · DOI · Paper page
  61. R M Gibson, 1997, Dissecting the Cooperative Reassociation of the Regulatory and Catalytic Subunits of cAMP-dependent Protein Kinase: Role of Trp-196 in the catalytic subunit, J Biol Chem, 272, 31998, 10.1074/jbc.272.51.31998 · DOI · Paper page
  62. J N Honeyman, 2014, Detection of a Recurrent DNAJB1-PRKACA Chimeric Transcript in Fibrolamellar Hepatocellular Carcinoma, Science, 343, 1010, 10.1126/science.1249484 · DOI · Paper page
  63. J Cheung, 2015, Structural insights into mis-regulation of protein kinase A in human tumors, Proc Natl Acad Sci USA, 112, 1374, 10.1073/pnas.1424206112 · DOI · Paper page
  64. R Rock, 2015, Impact of kinase activating and inactivating patient mutations on binary PKA interactions, Front Pharmacol, 6, 170

Cited by

See all 19

Metadata

Authors
Calebiro, D., Bathon, K., & Weigand, I.
Affiliations
  • Institute of Pharmacology and Toxicology, University Hospital, University of Würzburg, Würzburg, Germany
  • Department of Medicine I, Endocrine and Diabetes Unit, University Hospital, University of Würzburg, Würzburg, Germany
Venue
Hormone and Metabolic Research
Published
2016-11-03
Volume
49
Issue
04
Pages
307-314
ISSN
  • 0018-5043
  • 1439-4286
Cited by
19
References
7
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mechanisms of Aberrant PKA Activation by Cα Subunit Mutations. https://app.cochat.ai/papers/10.1055/s-0042-112817
The paper
Calebiro, D., Bathon, K., & Weigand, I. (2017). Mechanisms of Aberrant PKA Activation by Cα Subunit Mutations. Hormone and Metabolic Research. https://doi.org/10.1055/s-0042-112817

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.